Kandasamy Sujane, Khalid Ahmad Firas, Majid Umair, Vanstone Meredith
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON.
Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON.
Ont Health Technol Assess Ser. 2017 May 1;17(7):1-32. eCollection 2017.
Men with low- to intermediate-risk prostate cancer are typically asked to choose from a variety of treatment options, including active surveillance, radical prostatectomy, or brachytherapy. The Prolaris cell cycle progression test is intended to provide additional information on personal risk status to assist men with prostate cancer in their choice of treatment. To assist with assessing that new technology, this report synthesizes qualitative research on how men with prostate cancer use information to make decisions about treatment options.
We performed a systematic review and qualitative meta-synthesis to retrieve and synthesize findings across primary qualitative studies that report on patient perspectives during prostate cancer treatment decision-making.
Of 8,610 titles and abstracts reviewed, 29 studies are included in this report. Most men diagnosed with prostate cancer express that their information-seeking pathway extends beyond the medical information received from their health care provider. They access other social resources to attain additional medical information, lived-experience information, and medical administrative information to help support their final treatment decision. Men value privacy, trust, honesty, control, power, organization, and open communication during interactions with their health care providers. They also emphasize the importance of gaining comfort with their treatment choice, having a chance to confirm their health care provider's recommendations (validation of treatment plan), and exercising their preferred level of independence in the treatment decision-making process.
Although each prostate cancer patient is unique, studies suggest that most patients seek extensive information to help inform their treatment decisions. This may happen before, during, and after the treatment choice is made. Given the amount of information patients may access, it is important that they also establish the trustworthiness of the various types and sources of information. When information conflicts, patients may be unsure about how to proceed. Open collaboration between patients and their health care providers can help patients manage and navigate their concerns so that their values and perspectives are captured in their treatment choices.
患有低至中度风险前列腺癌的男性通常需要从多种治疗方案中进行选择,包括主动监测、根治性前列腺切除术或近距离放射治疗。Prolaris细胞周期进展测试旨在提供有关个人风险状况的更多信息,以帮助前列腺癌患者选择治疗方案。为了协助评估这项新技术,本报告综合了关于前列腺癌患者如何利用信息来做出治疗方案决策的定性研究。
我们进行了一项系统综述和定性元分析,以检索和综合主要定性研究的结果,这些研究报告了前列腺癌治疗决策过程中患者的观点。
在审查的8610篇标题和摘要中,本报告纳入了29项研究。大多数被诊断患有前列腺癌的男性表示,他们获取信息的途径不仅限于从医疗保健提供者那里获得的医学信息。他们还利用其他社会资源来获取更多的医学信息、生活经验信息和医疗管理信息,以帮助支持他们的最终治疗决策。男性在与医疗保健提供者互动时重视隐私、信任、诚实、控制、权力、组织和开放沟通。他们还强调在治疗选择中感到安心、有机会确认医疗保健提供者的建议(验证治疗方案)以及在治疗决策过程中行使自己偏好的独立程度的重要性。
尽管每位前列腺癌患者都是独特的,但研究表明,大多数患者会寻求广泛的信息来帮助做出治疗决策。这可能发生在做出治疗选择之前、期间和之后。鉴于患者可能获取的信息量,重要的是他们也要确定各种类型和来源信息的可信度。当信息相互冲突时,患者可能不确定如何继续。患者与其医疗保健提供者之间的开放合作可以帮助患者管理和应对他们的担忧,以便他们的价值观和观点能够体现在治疗选择中。